PATHWORK DIAGNOSTICS TISSUE OF ORIGIN TEST

PATHWORK DIAGNOSTICS, INC. · K080896 · 2008-07-30

PATHWORK DIAGNOSTICS TISSUE OF ORIGIN TEST is an AI-enabled medical device from PATHWORK DIAGNOSTICS, INC., listed by FDA (510(k), K080896) with a decision date of 2008-07-30. Review panel: Clinical Toxcicology.

FDA submission numberK080896
Pathway510(k)
CompanyPATHWORK DIAGNOSTICS, INC.
Review panel (specialty)Clinical Toxcicology
FDA decision date2008-07-30
DecisionUnknown
Product codeOIW
ClassificationSoftware, Similarity Score Algorithm, Tissue Of Origin For Malignant Tumor Types
Device class2
Regulation number862.3100
Review time (calendar days)121
Applicant countryUS

Official FDA database record · FDA AI-enabled device list

All Clinical Toxcicology AI devices · Full device index

Data from FDA's AI-enabled device list and openFDA. Informational only; verify against the FDA record.